DHC
Diversified Healthcare TrustPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Equibles Research
All DHC researchGuidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Medical office and life science square feet | 5.6M | As of March 31, 2026 | — |
| Net Debt to Annualized Adjusted EBITDAre non-GAAP | 7.8 | As of March 31, 2026 | — |
| Normalized FFO per Share non-GAAP | $0.14 | Q1 2026 | — |
| Same Property Cash Basis NOI Consolidated | $75,896K | Q1 2026 | — |
| Same Property Cash Basis NOI Medical Office and Life Science Portfolio | $24,683K | Q1 2026 | — |
| Same Property Cash Basis NOI SHOP | $44,321K | Q1 2026 | — |
| Same Property Occupancy Medical Office and Life Science Portfolio | 95.3% | Q1 2026 | — |
| Same Property Occupancy SHOP | 82.4% | Q1 2026 | — |
| Total Liquidity | $271.8M | As of March 31, 2026 | — |
| adjusted EBITDA RE non-GAAP | $74M | Q1 2026 call | — |
| consolidated NOI non-GAAP | $75.9M | Q1 2026 call | — |
| consolidated same property cash-basis NOI non-GAAP | $75.9M | Q1 2026 call | — |
| net debt to annualized adjusted EBITDA RE non-GAAP | 7.8 | Q1 2026 call | — |
| revolving credit facility availability | $150M | Q1 2026 call | — |
| same property medical office and life science NOI non-GAAP | $25.4M | Q1 2026 call | — |
| same property medical office and life science occupancy | 95.3% | Q1 2026 call | — |
| same property shop average monthly rate growth | 5.9% | Q1 2026 call | — |
| same property shop NOI non-GAAP | $44.3M | Q1 2026 call | — |
| same property shop NOI margin non-GAAP | 14.9% | Q1 2026 call | — |
| same property shop occupancy | 82.4% | Q1 2026 call | — |
| same property shop occupancy growth | 110 | Q1 2026 call | — |
| unencumbered properties | 197 | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DHC
this stock
Diversified Healthcare Trust
|
$2.23B | +84.5% | +18.2% | — | 5.0% |
|
WELL
Welltower Inc.
|
$170.47B | +26.1% | +35.6% | 120.1 | 2.7% |
|
VTR
Ventas, Inc.
|
$46.21B | +23.6% | +18.5% | 172.8 | 4.7% |
|
DOC
Healthpeak Properties, Inc.
|
$15.39B | +37.7% | +4.5% | 69.8 | 3.9% |
|
OHI
Omega Healthcare Investors Inc
|
$14.85B | +9.8% | +13.2% | 24.0 | 4.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DHC | -1.1% | +1.0% | +48.9% | -4.0% | +84.5% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | -2.4% | +1.2% | +38.7% | -5.1% | +73.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.